Drug intelligence / Profile preview

plasma-lyte

Development stage
Phase 4
Lead developer
Baxter
Modality
Small Molecules
Administration
Intravenous
01

Overview

Plasma-lyte is a sterile, nonpyrogenic isotonic crystalloid solution for intravenous infusion that contains a balanced mixture of electrolytes designed to closely mimic the composition of human plasma. The typical formulation includes sodium chloride, sodium gluconate, sodium acetate trihydrate, potassium chloride, and magnesium chloride hexahydrate in water for injection. It is used primarily as a source of water and electrolytes for fluid replacement in clinical situations such as burns, trauma, surgery (intraoperative fluid replacement), hemorrhagic shock requiring rapid blood transfusion compatibility with blood products, and mild to moderate metabolic acidosis including cases where lactate metabolism is impaired[1][2][3][4][5]. Acetate and gluconate serve as bicarbonate precursors providing an alkalinizing effect by being metabolized to carbon dioxide and water[1][3]. The main pharmacological action is expansion of the extracellular compartment (interstitial and intravascular fluids) with minimal risk of acid-base disturbance due to its physiologic pH (~7.4) and osmolarity (~295 mOsm/L)[2][3].

Brand names
Plasma-LytePlasma-Lyte 148Plasma-Lyte148Plasma-Lyte-148Plasma-Lyte A
Other names
Multiple Electrolytes Injection Type 1Plasma-Lyte 148 (pH 7.4)Plasma-Lyte A (pH 7.4)

Beyond the preview

Go deeper on plasma-lyte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on plasma-lyte.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call